Welcome to LookChem.com Sign In|Join Free
  • or
Piperazine, 1-[(5-formyl-4-methyl-1H-pyrrol-2-yl)carbonyl]-4-methyl- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

346600-38-2

Post Buying Request

346600-38-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

346600-38-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 346600-38-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,4,6,6,0 and 0 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 346600-38:
(8*3)+(7*4)+(6*6)+(5*6)+(4*0)+(3*0)+(2*3)+(1*8)=132
132 % 10 = 2
So 346600-38-2 is a valid CAS Registry Number.

346600-38-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-methyl-5-(4-methylpiperazine-1-carbonyl)-1H-pyrrole-2-carbaldehyde

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:346600-38-2 SDS

346600-38-2Downstream Products

346600-38-2Relevant academic research and scientific papers

4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors

-

, (2008/06/13)

This invention relates to 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors. Particular 4-substituted 7-aza-indolin-2-ones disclosed herein are of Formula 1 and pharmaceutically acceptable salts, solvates, clathrates, and prodrugs thereof, wherein R1, R2, R3, R4, X, Y, and Z are defined herein. The invention fuirther relates to pharmaceutical compositions and dosage forms comprising compounds of Formula 1 and to methods of their use for the treatment and/or prevention of diseases such as, but not limited to, cancer.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 346600-38-2